
Loading, please wait...

Loading, please wait...

Hypothalamic POMC neurons have long been recognized for their role in managing energy balance. However, recent findings suggest that neuronal glycogen metabolism is the primary engine allowing these neurons to respond to sensory food cues before any food is actually eaten. Specifically, this rapid metabolic activation prepares the body for nutrient intake by triggering early physiological responses.
Researchers found that depleting glycogen in these specific neurons makes the brain blind to the sight and smell of food. Consequently, the body fails to initiate the cephalic phase insulin release, which is a vital early step in glucose control. Furthermore, this breakdown in communication between the brain and the liver often leads to a prediabetic phenotype. Over time, these metabolic gaps progress into overt diabetes and weight gain, particularly when combined with a high-calorie diet.
Ultimately, this study proves that glycogen is not just an energy backup for the liver or muscles. Instead, it serves as a decisive fuel for the brain's rapid energy demands during sensory perception. By understanding how neuronal glycogen metabolism functions, clinicians can better appreciate the complex neurological triggers behind metabolic syndrome. This knowledge may eventually lead to new therapies targeting brain metabolism to manage obesity and blood sugar levels.
POMC neurons in the hypothalamus respond to the sight and smell of food to prime the body for digestion and early insulin release.
Without adequate glycogen, POMC neurons cannot activate in response to food cues. This failure causes impaired insulin release and hepatic adaptations that eventually result in insulin resistance.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Gómez-Valadés AG et al. Glycogen drives the sensory activation of POMC neurons. Nat Metab. 2026 May 27. doi: 10.1038/s42255-026-01535-7. PMID: 42204369.
Teff KL. The elusive cephalic phase insulin response: triggers, mechanisms, and functions. Am J Physiol Regul Integr Comp Physiol. 2011 Dec;301(6):R1531-44.
Duran J, et al. The Multifaceted Roles of Brain Glycogen. Front Cell Neurosci. 2021 Jul 15;15:675773.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers discover that hypothalamic POMC neurons rely on glycogen to sense food cues, a process critical for preventing obesity and diabetes....
3 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today